Joseph Ronald Catapano - 27 Feb 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
27 Feb 2026
Net transactions value
-$6,821
Form type
4
Filing time
03 Mar 2026, 16:09:03 UTC
Previous filing
06 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Catapano Joseph Ronald Chief Accounting Officer C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 03 Mar 2026 0001714468

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +3,333 +50% 10,019 27 Feb 2026 Direct F1
transaction TDOC Common Stock Options Exercise +155 +1.5% 10,174 27 Feb 2026 Direct F2
transaction TDOC Common Stock Sale $6,821 -1,333 -13% $5.12 8,841 02 Mar 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -3,333 -33% $0.000000 6,667 27 Feb 2026 Common Stock 3,333 Direct F1, F4
transaction TDOC Performance Stock Units Award $0 +465 $0.000000 465 27 Feb 2026 Common Stock 465 Direct F5, F6
transaction TDOC Performance Stock Units Options Exercise $0 -155 -33% $0.000000 310 27 Feb 2026 Common Stock 155 Direct F2, F7
transaction TDOC Restricted Stock Units Award $0 +15,000 $0.000000 15,000 01 Mar 2026 Common Stock 15,000 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F6 Performance award amount determined based on metrics in respect of the issuer's 2025 financial results.
F7 On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F9 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.